SLU-PP-332

SLU-PP-332 enhances endurance capacity.

Research indicates that activation of ERR pathways significantly improves endurance in preclinical models. Subjects demonstrated increased running capacity and sustained energy output without prior conditioning.

SLU-PP-332 promotes fat oxidation.

Studies show that ERR agonists shift metabolism toward increased fatty acid utilization. This leads to greater fat burning and improved metabolic flexibility.

SLU-PP-332 supports mitochondrial function.

Research has demonstrated that SLU-PP-332 increases mitochondrial density and efficiency, enhancing the body’s ability to produce energy at the cellular level.

SLU-PP-332 mimics exercise-related pathways.

Preclinical studies suggest that SLU-PP-332 activates similar molecular pathways as endurance exercise, including those involved in oxidative metabolism and energy expenditure.

SLU-PP-332 improves metabolic efficiency.

Activation of ERR receptors has been linked to improved energy utilization, allowing cells to generate more ATP while reducing metabolic waste.

SLU-PP-332 may support weight management research.

By increasing fat oxidation and energy expenditure, studies suggest SLU-PP-332 may play a role in regulating body composition and reducing adiposity.

SLU-PP-332 enhances skeletal muscle adaptation.

Research indicates that ERR activation promotes gene expression linked to muscle endurance and oxidative capacity, improving muscle performance over time.

SLU-PP-332 supports glucose metabolism.

Studies show improved glucose utilization and insulin sensitivity through enhanced mitochondrial activity and metabolic signaling pathways.

SLU-PP-332 may support cardiovascular endurance.

Preclinical findings suggest improved oxygen utilization and cardiovascular efficiency, key components of endurance performance.

SLU-PP-332 influences longevity pathways.

By enhancing mitochondrial health and energy regulation, SLU-PP-332 is being studied for its role in pathways associated with aging and cellular resilience.

SLU-PP-332 is a selective estrogen-related receptor (ERR) agonist that plays a key role in regulating energy metabolism and mitochondrial function. Below is a detailed explanation of its action:

Activation of Estrogen-Related Receptors (ERRs): SLU-PP-332 selectively activates ERRα, ERRβ, and ERRγ, nuclear receptors that function as transcription factors regulating genes involved in energy production and metabolic processes. This activation initiates changes in gene expression related to cellular energy dynamics.

Upregulation of Mitochondrial Biogenesis: Through ERR activation, SLU-PP-332 promotes the expression of genes responsible for mitochondrial biogenesis and function. This leads to an increase in both the number and efficiency of mitochondria, enhancing the cell’s ability to generate energy.

Enhancement of Oxidative Metabolism: SLU-PP-332 shifts cellular metabolism toward increased oxidative phosphorylation. This improves the body’s ability to utilize fatty acids and glucose as fuel sources, supporting sustained energy production and metabolic efficiency.

Exercise-Mimetic Signaling: By activating pathways typically stimulated during physical activity, SLU-PP-332 mimics certain effects of endurance exercise at the molecular level. This includes increased energy expenditure and improved metabolic flexibility without the need for physical exertion.

Regulation of Fatty Acid Oxidation: The compound enhances the expression of genes involved in fatty acid transport and oxidation, promoting the breakdown of stored fat for energy and supporting research into body composition and metabolic health.

Systemic Metabolic Effects: The downstream effects of ERR activation influence whole-body energy balance, endurance capacity, and metabolic resilience. These pathways are central to ongoing research in obesity, performance optimization, and age-related metabolic decline.

Intended Use: SLU-PP-332 is designed for Research Purposes only.

Storage: Store in a cool, dry place away from direct sunlight. Refrigeration is recommended for long-term stability.

Solubility: Soluble in DMSO or other appropriate research-grade solvents. Further dilution may be required depending on study parameters.

Shelf Life: Stable for up to 24 months when properly stored. Once prepared in solution, refrigerate and use within 4–6 weeks.

Handling: Use proper laboratory safety and sterile handling procedures to maintain compound integrity during research.